Cargando…
Two cases of infantile-onset primary generalized glucocorticoid hypersensitivity and the effect of mifepristone
BACKGROUND: Primary generalized glucocorticoid hypersensitivity (PGGH) is a very rare disease caused by terminal organ hypersensitivity to glucocorticoids for which the aetiology is unknown. The incidence of PGGH is extremely rare, especially in children. To date, the literatures about the etiology,...
Autores principales: | Zhao, Xiu, Xu, Zhongwei, Su, Huiping, Zheng, Rongfei, Zhan, Min, Huang, Yuge, Su, Zhe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641862/ https://www.ncbi.nlm.nih.gov/pubmed/36348308 http://dx.doi.org/10.1186/s12887-022-03722-3 |
Ejemplares similares
-
Primary Generalized Glucocorticoid Hypersensitivity Treated with Mifepristone: A Case Report
por: Liu, Yunfeng, et al.
Publicado: (2020) -
Primary Generalized Glucocorticoid Resistance and Hypersensitivity Syndromes: A 2021 Update
por: Nicolaides, Nicolas C., et al.
Publicado: (2021) -
Acute generalized exanthematous pustulosis induced by mifepristone
por: Kirsch, Brandon M., et al.
Publicado: (2015) -
Mifepristone Plasma Level and Glucocorticoid Receptor Antagonism Associated With Response in Patients With Psychotic Depression
por: Block, Thaddeus, et al.
Publicado: (2017) -
Effects of Ketoconazole on the Pharmacokinetics of Mifepristone, a Competitive Glucocorticoid Receptor Antagonist, in Healthy Men
por: Nguyen, Dat, et al.
Publicado: (2017)